These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27556929)

  • 21. Professionalism and physician interactions with industry.
    Collins J
    J Am Coll Radiol; 2006 May; 3(5):325-32. PubMed ID: 17412075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in Japanese physicians' relationships with the pharmaceutical industry between 2008 and 2021: A national survey.
    Saito S; Mukohara K; Shimomura K; Murotani K
    PLoS One; 2023; 18(6):e0286339. PubMed ID: 37262046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between physicians and pharmaceutical representatives, an insight from Thailand.
    Srinonprasert V; Arrunyagasamesuke A; Nimmannit A; Sutheechet K; Wongwatcharadeth P; Phattharayuttawat S; Pongprasobchai S
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S223-31. PubMed ID: 24772602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
    Katz D; Caplan AL; Merz JF
    Am J Bioeth; 2003; 3(3):39-46. PubMed ID: 14594489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicians and the pharmaceutical industry: impact on prescription attitudes and habits.
    Peredo-Silva L; Lifshitz A; Reyes-Morales H; Mino-León D
    Gac Med Mex; 2020; 156(6):546-552. PubMed ID: 33877108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis.
    Brax H; Fadlallah R; Al-Khaled L; Kahale LA; Nas H; El-Jardali F; Akl EA
    PLoS One; 2017; 12(4):e0175493. PubMed ID: 28406971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and Japan.
    Rodwin MA
    J Law Med Ethics; 2011; 39(4):662-70. PubMed ID: 22084852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicians' attitudes towards interaction with the pharmaceutical industry.
    Alosaimi FD; Al Kaabba A; Qadi M; Albahlal A; Alabdulkarim Y; Alabduljabbar M; Alqahtani F
    East Mediterr Health J; 2015 Feb; 20(12):812-9. PubMed ID: 25664520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physician report of industry gifts and quality of care.
    Lee D; Begley CE
    Health Care Manage Rev; 2016; 41(3):275-83. PubMed ID: 25427138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Madison hospitals say no to food, gifts, trinkets.
    Thompson CA
    Am J Health Syst Pharm; 2006 Dec; 63(24):2438, 2441. PubMed ID: 17158689
    [No Abstract]   [Full Text] [Related]  

  • 31. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
    Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
    BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attitudes and practices of medical graduates in Delhi towards gifts from the pharmaceutical industry.
    Sharma V; Aggarwal S; Singh H; Garg S; Sharma A; Sharma R
    Indian J Med Ethics; 2010; 7(4):223-5. PubMed ID: 22106572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
    Katz D; Caplan AL; Merz JF
    Am J Bioeth; 2010 Oct; 10(10):11-7. PubMed ID: 20945262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between Opioid Prescribing in Medicare and Pharmaceutical Company Gifts by Physician Specialty.
    Hollander MAG; Donohue JM; Stein BD; Krans EE; Jarlenski MP
    J Gen Intern Med; 2020 Aug; 35(8):2451-2458. PubMed ID: 31792860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Legislative, educational, policy and other interventions targeting physicians' interaction with pharmaceutical companies: a systematic review.
    Alkhaled L; Kahale L; Nass H; Brax H; Fadlallah R; Badr K; Akl EA
    BMJ Open; 2014 Jul; 4(7):e004880. PubMed ID: 24989618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gifts to physicians from the pharmaceutical industry: an ethical analysis.
    Marco CA; Moskop JC; Solomon RC; Geiderman JM; Larkin GL
    Ann Emerg Med; 2006 Nov; 48(5):513-21. PubMed ID: 17052550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States.
    King M; Bearman PS
    Soc Sci Med; 2017 Jan; 172():153-162. PubMed ID: 27856120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
    Wofford JL; Ohl CA
    BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts.
    Gibbons RV; Landry FJ; Blouch DL; Jones DL; Williams FK; Lucey CR; Kroenke K
    J Gen Intern Med; 1998 Mar; 13(3):151-4. PubMed ID: 9541370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.